Implied Volatility Surging for UFP Technologies Stock Options

Investors need to pay close attention to UFPT stock based on the movements in the options market lately.

Zacks Investment Research • Sep 9, 2026

3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes

GenAI offers growth potential for VCYT, GMED and UFPT, but regulatory and technology risks are likely to challenge adoption across healthcare.

Zacks Investment Research • Sep 9, 2026

UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares

The sale represents a total value of $324,260. The disposition was executed entirely through direct ownership, leaving the insider with 4,476 shares held directly.

The Motley Fool • Aug 31, 2026

UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds

UFP Technologies NASDAQ: UFPT outlined its strategy to expand through organic growth and acquisitions, emphasizing its role as a contract development and manufacturing organization serving medical-device companies.

MarketBeat • Aug 28, 2026

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL

NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), today announced Mitchell Rock, President and Chief Executive Officer, and Ron Lataille, Sr. Vice President, Treasurer and Chief Financial Officer, will present and host 1-on-1 meetings at the Midwest IDEAS Investor Conference on Wednesday, August 26, 2026 at The InterContinental in Chicago, IL. The company's presentation is scheduled to begin at 8:35 AM CT. The presentation is webcast and can be accessed through the con.

Business Wire • Aug 20, 2026

Why UFP Technologies Stock Is Skyrocketing Today

UFP Technologies grew sales and adjusted earnings per share by 15% and 17% in the second quarter. This was even though its largest product category -- robotic surgery drapes -- was largely flat.

The Motley Fool • Aug 4, 2026

UFP Technologies Q2 Earnings Call Highlights

UFP Technologies NASDAQ: UFPT reported second-quarter 2026 sales growth of 15.1% to $174 million, supported by broad-based demand across its medical technology portfolio, while adjusted earnings per share rose 16.8% to a company-record $2.92.

MarketBeat • Aug 4, 2026

UFP Technologies, Inc. (UFPT) Q2 2026 Earnings Call Transcript

UFP Technologies, Inc. (UFPT) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 4, 2026

UFP Technologies Announces Record Q2 Results

NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.9 million for its second quarter ended June 30, 2026, 21.4% higher than net income of $17.2 million for the second quarter of 2025. Net sales for the quarter ended June 30, 2026 were $174.0 million, 15.1%.

Business Wire • Aug 3, 2026

UFP Technologies (UFPT) Beats Q2 Earnings and Revenue Estimates

UFP Technologies (UFPT) came out with quarterly earnings of $2.92 per share, beating the Zacks Consensus Estimate of $2.51 per share. This compares to earnings of $2.5 per share a year ago.

Zacks Investment Research • Aug 3, 2026